Weis Holger — SEC insider filings
SEC reporting owner CIK 1846984. 17 insider filings on record with FilingPulse; latest filed 2026-10-08.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2021-05-06 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 50,000 shares, $91,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: purchase of 50,000 shares @ $1.83 ($91,500) in Alaunos Therapeutics, Inc., filed 2021-09-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | CEO | 14 | 1 leg · 50,000 sh · $91,500 | — | 17 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | Director | 3 | — | — | 5 |
Insider filings — Weis Holger
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-08 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 23,564 @ $0.74 | EDGAR |
| 2026-08-11 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 4,363 @ $2.01 | EDGAR |
| 2026-07-27 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 4,568 @ $1.92 | EDGAR |
| 2026-07-13 | 4 | JUPITER NEUROSCIENCES, INC. (JUNS) | Option exercise (M): 85,800 · Option exercise (M): 85,800 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 3,880 @ $2.26 | EDGAR |
| 2026-06-17 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 7,761 @ $2.26 | EDGAR |
| 2026-06-04 | 4 | JUPITER NEUROSCIENCES, INC. (JUNS) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 3,700 @ $2.37 | EDGAR |
| 2025-08-20 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 13,676 (derivative) @ $0 | EDGAR |
| 2025-07-07 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2025-04-15 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 10,904 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | JUPITER NEUROSCIENCES, INC. (JUNS) | Option exercise (M): 10,781 · Option exercise (M): 10,781 (derivative) @ $2.80 | EDGAR |
| 2024-06-10 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 19,200 (derivative) @ $0 · Grant/award (A): 4,524 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Alaunos Therapeutics, Inc. (TCRT) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-09-03 | 4 | ZIOPHARM ONCOLOGY INC (ZIOP) | Purchase (P): 50,000 @ $1.83 | EDGAR |
| 2021-05-06 | 4 | ZIOPHARM ONCOLOGY INC (ZIOP) | Grant/award (A): 4,167 @ $0 · Grant/award (A): 31,250 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1846984 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs